1. Home
  2. IZEA vs IVVD Comparison

IZEA vs IVVD Comparison

Compare IZEA & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

N/A

Current Price

$3.69

Market Cap

78.8M

ML Signal

N/A

Logo Invivyd Inc.

IVVD

Invivyd Inc.

N/A

Current Price

$1.90

Market Cap

437.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IZEA
IVVD
Founded
2006
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.8M
437.1M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
IZEA
IVVD
Price
$3.69
$1.90
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.75
AVG Volume (30 Days)
56.0K
1.7M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
0.07
N/A
Revenue
$20,099,695.00
$53,426,000.00
Revenue This Year
N/A
$143.48
Revenue Next Year
$15.91
$25.40
P/E Ratio
$51.43
N/A
Revenue Growth
N/A
110.47
52 Week Low
$1.68
$0.46
52 Week High
$5.86
$3.07

Technical Indicators

Market Signals
Indicator
IZEA
IVVD
Relative Strength Index (RSI) 50.84 57.57
Support Level $3.48 $1.41
Resistance Level $3.85 $2.01
Average True Range (ATR) 0.17 0.11
MACD 0.04 0.05
Stochastic Oscillator 57.58 80.90

Price Performance

Historical Comparison
IZEA
IVVD

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: